A detailed history of Victory Capital Management Inc transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 4,569 shares of TMDX stock, worth $300,228. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,569
Previous 4,105 11.3%
Holding current value
$300,228
Previous $618,000 16.02%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$135.68 - $176.11 $62,955 - $81,715
464 Added 11.3%
4,569 $717,000
Q2 2024

Aug 05, 2024

SELL
$72.62 - $150.62 $2,686 - $5,572
-37 Reduced 0.89%
4,105 $618,000
Q1 2024

May 03, 2024

SELL
$70.86 - $89.93 $6,873 - $8,723
-97 Reduced 2.29%
4,142 $306,000
Q4 2023

Feb 05, 2024

SELL
$36.74 - $81.08 $231,241 - $510,317
-6,294 Reduced 59.76%
4,239 $334,000
Q3 2023

Nov 06, 2023

BUY
$53.47 - $96.07 $81,755 - $146,891
1,529 Added 16.98%
10,533 $576,000
Q2 2023

Jul 27, 2023

BUY
$66.23 - $88.73 $366,516 - $491,031
5,534 Added 159.48%
9,004 $756,000
Q1 2023

May 02, 2023

BUY
$53.63 - $82.33 $8,688 - $13,337
162 Added 4.9%
3,470 $262,000
Q4 2022

Feb 10, 2023

BUY
$39.08 - $64.29 $1,133 - $1,864
29 Added 0.88%
3,308 $204,000
Q4 2022

Feb 09, 2023

SELL
$39.08 - $64.29 $189,694 - $312,063
-4,854 Reduced 59.68%
3,279 $202,000
Q3 2022

Nov 02, 2022

BUY
$31.56 - $55.75 $256,677 - $453,414
8,133 New
8,133 $339,000
Q2 2020

Aug 07, 2020

SELL
$11.66 - $18.26 $27,587 - $43,203
-2,366 Closed
0 $0
Q1 2020

May 04, 2020

BUY
$10.5 - $20.2 $5,554 - $10,685
529 Added 28.8%
2,366 $29,000
Q4 2019

Feb 04, 2020

BUY
$16.61 - $21.64 $13,570 - $17,679
817 Added 80.1%
1,837 $32,000
Q3 2019

Nov 12, 2019

BUY
$20.27 - $28.93 $20,675 - $29,508
1,020 New
1,020 $24,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.09B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.